Literature DB >> 28838209

Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.

C J Pezaro1, A Omlin2, K Mastris3, G Attard4, T M Beer5, K N Chi6, S Chowdhury7, I D Davis8, C G Drake9, J S de Bono4, E Efstathiou10, G Gravis11, C S Higano12, M Hussain13, N James14, C J Logothetis10,15, A Morgans16, C Parker17, C J Ryan18, F Saad19, O Sartor20, E J Small21, C N Sternberg22, C J Sweeney23, I Tannock24, B Tombal25, S Gillessen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28838209     DOI： 10.1093/annonc/mdx312

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Authors:  A J Armstrong; E S Antonarakis; M-E Taplin; W K Kelly; H Beltran; K Fizazi; W L Dahut; N Shore; S Slovin; D George; M A Carducci; P Corn; D Danila; R Dreicer; E Heath; D Rathkopf; G Liu; D Nanus; M Stein; M R Smith; C Sternberg; G Wilding; P S Nelson; S Halabi; P Kantoff; N W Clarke; C P Evans; A Heidenreich; N Mottet; M Gleave; M J Morris; H I Scher
Journal:  Ann Oncol       Date:  2018-01-01       Impact factor: 32.976

2.  Correcting "insertion-deletion mutations" in medical terminology.

Authors:  Alexios-Fotios A Mentis; Athanasios G Papavassiliou
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.